HOXA4: A Potential Drug Target for Cancer, Neurodegenerative Diseases and Autoimmune Disorders

Target Name: HOXA4

NCBI ID: G3201

HOXA4

HOXA4: A Potential Drug Target for Cancer, Neurodegenerative Diseases and Autoimmune Disorders

Homo box A4 (HOXA4) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The gene is located on chromosome 6p21 and has been shown to be involved in the development and progression of these diseases.

HOXA4 is a member of the homeobox gene family, which is known for the development of complex tissues and organs in animals. The homeobox genes are involved in the regulation of cell shape and the development of tissues during development. HOXA4 is specifically involved in the development of the anterior chamber of the eye, which is the part of the eye that contains the lens and the retina.

HOXA4 has been shown to be involved in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that HOXA4 is involved in the development of ovarian cancer by promoting the growth and proliferation of cancer cells.

Additionally, HOXA4 has also been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Studies have shown that HOXA4 is expressed in the brains of individuals with these conditions and that it is involved in the development and progression of these diseases.

HOXA4 has also been shown to be involved in the development of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. Studies have shown that HOXA4 is expressed in the tissues of individuals with these conditions and that it is involved in the development and progression of these diseases.

Despite the potential implications of HOXA4 as a drug target and biomarker, more research is needed to fully understand its role in these diseases. Studies are needed to determine the exact mechanisms by which HOXA4 promotes the growth and proliferation of cancer cells, the development and progression of neurodegenerative diseases, and the development of autoimmune disorders.

In conclusion, HOXA4 is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The gene is involved in the development and progression of these diseases and is a promising target for future research. Further studies are needed to fully understand its role in these conditions and to develop effective treatments.

Protein Name: Homeobox A4

Functions: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Binds to sites in the 5'-flanking sequence of its coding region with various affinities. The consensus sequences of the high and low affinity binding sites are 5'-TAATGA[CG]-3' and 5'-CTAATTTT-3'

The "HOXA4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HOXA4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets